Identification of Functional HLA-A*01:01–Restricted Epstein-Barr Latent Membrane Protein 2–Specific T-Cell Receptors

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders

(2019) James P. Dugan et al.   Frontiers in Oncology

Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function

(2019) Kilian Schober et al.   Nature Biomedical Engineering

Simultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic

(2019) Laura T. Morton et al.   MOLECULAR THERAPY

A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy

(2018) Hyun-Il Cho et al.   BRITISH JOURNAL OF CANCER

Peptide–MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations

(2018) Cristina Rius et al.   JOURNAL OF IMMUNOLOGY

EBV/LMP-specific T cells maintain remissions of T and B cell EBV lymphomas after allogeneic bone marrow transplantation

(2018) Lauren P. McLaughlin et al.   BLOOD

Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response

(2017) Cornelis A.M. van Bergen et al.   JOURNAL OF CLINICAL INVESTIGATION

Quantitative multi-target RNA profiling in Epstein-Barr virus infected tumor cells

(2017) A.E. Greijer et al.   JOURNAL OF VIROLOGICAL METHODS

Epstein–Barr virus-associated lymphomas

(2017) Claire Shannon-Lowe et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Gapped sequence alignment using artificial neural networks: application to the MHC class I system

(2015) Massimo Andreatta et al.   BIOINFORMATICS

The impact of HLA class I and EBV latency-II antigen-specific CD8+T cells on the pathogenesis of EBV+Hodgkin lymphoma

(2015) K. Jones et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB

(2015) Lielian Zuo et al.   Oncotarget

Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus-Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma

(2015) Y. Zheng et al.   Cancer Immunology Research

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

(2013) Catherine M. Bollard et al.   JOURNAL OF CLINICAL ONCOLOGY

Template-switching anchored polymerase chain reaction reliably amplifies functional lambda light chain transcripts of malignant lymphoma

(2013) Marvyn T. Koning et al.   LEUKEMIA & LYMPHOMA

The Effect of Epstein-Barr Virus Latent Membrane Protein 2 Expression on the Kinetics of Early B Cell Infection

(2013) Laura R. Wasil et al.   PLoS One

Molecular immunology lessons from therapeutic T-cell receptor gene transfer

(2010) Sharyn Thomas et al.   IMMUNOLOGY

A mechanism for the HLA-A*01-associated risk for EBV+ Hodgkin lymphoma and infectious mononucleosis

(2008) R. M. Brennan et al.   BLOOD